Sodium-glucose cotransporter 2 inhibitors and the risk of diabetic ketoacidosis: from pathophysiology to clinical practice
Background: SGLT-2 inhibitors are a novel class of antidiabetic drugs, recently - approved for the treatment of patients with T2DM. Their cardioprotective an...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
[2018]
|
| In: |
Cardiovascular & hematological disorders, drug targets
Year: 2018, Jahrgang: 18, Pages: 139-146 |
| ISSN: | 2212-4063 |
| DOI: | 10.2174/1871529X18666180206123149 |
| Online-Zugang: | Resolving-System, Volltext: https://doi.org/10.2174/1871529X18666180206123149 Verlag, Volltext: http://www.eurekaselect.com/159592/article 
|
| Verfasserangaben: | Dimitrios Patoulias, Alexandros Manafis, Christos Mitas, Konstantinos Avranas, Georgios Lales, Ioanna Zografou, Christos Sambanis and Asterios Karagiannis |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1690282347 | ||
| 003 | DE-627 | ||
| 005 | 20230427083234.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 200218s2018 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)1690282347 | ||
| 035 | |a (DE-599)KXP1690282347 | ||
| 035 | |a (OCoLC)1341305791 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Patoulias, Dimitrios |e VerfasserIn |0 (DE-588)1204961387 |0 (DE-627)1690281928 |4 aut | |
| 245 | 1 | 0 | |a Sodium-glucose cotransporter 2 inhibitors and the risk of diabetic ketoacidosis |b from pathophysiology to clinical practice |c Dimitrios Patoulias, Alexandros Manafis, Christos Mitas, Konstantinos Avranas, Georgios Lales, Ioanna Zografou, Christos Sambanis and Asterios Karagiannis |
| 264 | 1 | |c [2018] | |
| 300 | |a 8 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 18.02.2020 | ||
| 520 | |a Background: SGLT-2 inhibitors are a novel class of antidiabetic drugs, recently - approved for the treatment of patients with T2DM. Their cardioprotective an... | ||
| 700 | 1 | |a Avranas, Konstantinos |d 1989- |e VerfasserIn |0 (DE-588)1204961212 |0 (DE-627)1690281359 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Cardiovascular & hematological disorders, drug targets |d Sharjah [u.a.] : Bentham Science Publ., 2006 |g 18(2018), Seite 139-146 |h Online-Ressource |w (DE-627)518959155 |w (DE-600)2254232-2 |w (DE-576)273891057 |x 2212-4063 |7 nnas |a Sodium-glucose cotransporter 2 inhibitors and the risk of diabetic ketoacidosis from pathophysiology to clinical practice |
| 773 | 1 | 8 | |g volume:18 |g year:2018 |g pages:139-146 |g extent:8 |a Sodium-glucose cotransporter 2 inhibitors and the risk of diabetic ketoacidosis from pathophysiology to clinical practice |
| 856 | 4 | 0 | |u https://doi.org/10.2174/1871529X18666180206123149 |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u http://www.eurekaselect.com/159592/article |x Verlag |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20200218 | ||
| 993 | |a Article | ||
| 994 | |a 2018 | ||
| 998 | |g 1204961212 |a Avranas, Konstantinos |m 1204961212:Avranas, Konstantinos |d 910000 |d 910100 |e 910000PA1204961212 |e 910100PA1204961212 |k 0/910000/ |k 1/910000/910100/ |p 4 | ||
| 999 | |a KXP-PPN1690282347 |e 3596613434 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"title":[{"title":"Sodium-glucose cotransporter 2 inhibitors and the risk of diabetic ketoacidosis","subtitle":"from pathophysiology to clinical practice","title_sort":"Sodium-glucose cotransporter 2 inhibitors and the risk of diabetic ketoacidosis"}],"person":[{"role":"aut","display":"Patoulias, Dimitrios","roleDisplay":"VerfasserIn","given":"Dimitrios","family":"Patoulias"},{"given":"Konstantinos","family":"Avranas","role":"aut","roleDisplay":"VerfasserIn","display":"Avranas, Konstantinos"}],"recId":"1690282347","language":["eng"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"note":["Gesehen am 18.02.2020"],"id":{"eki":["1690282347"]},"origin":[{"dateIssuedKey":"2018","dateIssuedDisp":"[2018]"}],"name":{"displayForm":["Dimitrios Patoulias, Alexandros Manafis, Christos Mitas, Konstantinos Avranas, Georgios Lales, Ioanna Zografou, Christos Sambanis and Asterios Karagiannis"]},"relHost":[{"type":{"media":"Online-Ressource","bibl":"periodical"},"disp":"Sodium-glucose cotransporter 2 inhibitors and the risk of diabetic ketoacidosis from pathophysiology to clinical practiceCardiovascular & hematological disorders, drug targets","note":["Gesehen am 03.07.23"],"language":["eng"],"recId":"518959155","pubHistory":["6.2006 -"],"part":{"extent":"8","text":"18(2018), Seite 139-146","volume":"18","pages":"139-146","year":"2018"},"titleAlt":[{"title":"Cardiovascular and hematological disorders, drug targets"},{"title":"Cardiovascular & haematological disorders, drug targets"}],"title":[{"title_sort":"Cardiovascular & hematological disorders, drug targets","title":"Cardiovascular & hematological disorders, drug targets"}],"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"dateIssuedDisp":"2006-","publisher":"Bentham Science Publ.","dateIssuedKey":"2006","publisherPlace":"Sharjah [u.a.]"}],"id":{"issn":["2212-4063"],"eki":["518959155"],"zdb":["2254232-2"]}}],"physDesc":[{"extent":"8 S."}]} | ||
| SRT | |a PATOULIASDSODIUMGLUC2018 | ||